Our projects

Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...

Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.

Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.

Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...

Establishing a research integrity frameworkThe SERCEA project aims to strengthen mechanisms that promote and ensure the integrity of scientific research in East Africa.

Preventing chikungunya infectionsThe ACT-CHIK project is advancing a new vaccine against the chikungunya virus to address its growing burden on African populations and health systems.

Simplifying treatment of neglected skin diseasesThe TEBULA project is advancing a potentially revolutionary new treatment for two neglected mycobacterial diseases: leprosy and Buruli ulcer.

Widening genomic surveillance in Southern and Eastern AfricaThe GenPath Africa project is expanding existing genomic surveillance infrastructure to capture information on drug-resistant...

Advancing malaria treatments for pregnant womenAdditional Global Health EDCTP3 funding is completing the evaluation of a new antimalarial treatment for pregnant women.

Preventing the return of tuberculosis The RECENT-TB project is exploring whether a course of preventive antibiotics after TB treatment can prevent disease recurrence and how to target those...

Building ‘One Health’ surveillance capacityThe PHM Hub project is strengthening epidemiology and disease-modelling capacity in West and Central Africa, with a particular focus on the human...

Mitigating the risk of antimalarial resistanceThe MARC-SE Africa project is enabling key countries in Africa to track and respond to rising rates of resistance to antimalarial drugs.

Community-based care for vulnerable children after hospital dischargeThe SDx project is assessing whether digital tools can enable community health workers to maintain contact with...

An adaptive trial platform for testing neonatal sepsis treatmentsThe SNIP-AFRICA project is establishing a research platform with an innovative trial design that will enable multiple...

Speeding up the diagnosis of tuberculosis meningitisThe PRECISE-TBM project aims to accelerate the detection of tuberculous meningitis, the deadliest form of TB that is a particular threat...

Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).

TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...

Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...

Targeting vectors for infection prediction and controlThe IMPACTING project is collecting data on a host of insect vectors that spread infections to help better predict the risk of...

Rapid testing of urinary tract infectionsThe UTI-Diag project is exploring whether point-of-care tests could improve detection and management of urinary tract infections (UTIs) and reduce...